These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25963450)

  • 21. Omalizumab (Xolair) for the treatment of chronic idiopathic urticarial.
    Scheinfeld N
    Skinmed; 2014; 12(5):294-7. PubMed ID: 25632648
    [No Abstract]   [Full Text] [Related]  

  • 22. [Systemic anaphylaxis and allergic reactions following administration of penicillins. Report to the Committee of Adverse Drug Reactions].
    Hovgaard C
    Ugeskr Laeger; 1985 May; 147(22):1791-2. PubMed ID: 4024326
    [No Abstract]   [Full Text] [Related]  

  • 23. Omalizumab in the treatment of chronic urticaria.
    Francés L; Leiva-Salinas M; Silvestre JF
    Actas Dermosifiliogr; 2014; 105(1):45-52. PubMed ID: 23938072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Omalizumab treatment in patients with asthma: summary of Meir Medical Center experience with 47 patients].
    Shitrit D; Talker O; Metabichek A; Yaakovi I
    Harefuah; 2012 Apr; 151(4):216-9, 254, 253. PubMed ID: 22616149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eligibility for treatment with omalizumab in Italy and Germany.
    Buhl R; Marco AG; Cohen D; Canonica GW
    Respir Med; 2014 Jan; 108(1):50-6. PubMed ID: 24315468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug disease in cardiology].
    Korochkin IM; Samoĭlova LN
    Sov Med; 1980; (1):10-4. PubMed ID: 7367963
    [No Abstract]   [Full Text] [Related]  

  • 27. Omalizumab in the treatment of asthma.
    Tan R; Corren J
    Expert Rev Respir Med; 2011 Dec; 5(6):747-56. PubMed ID: 22082161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omalizumab (Xolair) for chronic urticaria.
    Med Lett Drugs Ther; 2013 May; 55(1417):43-4. PubMed ID: 23715129
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention and treatment of complications caused by the use of antibiotics (literature survey)].
    Gostishchev VK; Tolstykh PI
    Vrach Delo; 1974; 0(7):13-8. PubMed ID: 4609356
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of anaphylaxis to palivizumab.
    Savitz J; Geaney C; Banks TA
    Ann Allergy Asthma Immunol; 2014 Aug; 113(2):236-7. PubMed ID: 25065351
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute infusion reactions induced by monoclonal antibody therapy.
    Maggi E; Vultaggio A; Matucci A
    Expert Rev Clin Immunol; 2011 Jan; 7(1):55-63. PubMed ID: 21162650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of exercise-induced anaphylaxis with omalizumab.
    Bray SM; Fajt ML; Petrov AA
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):281-2. PubMed ID: 23010237
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug allergy (first of three parts).
    Parker CW
    N Engl J Med; 1975 Mar; 292(10):511-4. PubMed ID: 1090822
    [No Abstract]   [Full Text] [Related]  

  • 34. Omalizumab in chronic urticaria.
    Metz M; Maurer M
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
    Tzortzaki EG; Georgiou A; Kampas D; Lemessios M; Markatos M; Adamidi T; Samara K; Skoula G; Damianaki A; Schiza S; Tzanakis N; Siafakas NM
    Pulm Pharmacol Ther; 2012 Feb; 25(1):77-82. PubMed ID: 22155001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergic bronchopulmonary aspergillosis and omalizumab.
    Tillie-Leblond I; Germaud P; Leroyer C; Tétu L; Girard F; Devouassoux G; Grignet JP; Prudhomme A; Dusser D; Wallaert B
    Allergy; 2011 Sep; 66(9):1254-6. PubMed ID: 21517902
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety of omalizumab in asthma.
    Tan RA; Corren J
    Expert Opin Drug Saf; 2011 May; 10(3):463-71. PubMed ID: 21401438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reactions and reporting.
    Witte R
    Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
    [No Abstract]   [Full Text] [Related]  

  • 39. [Allergic reactions during anesthesia--a national network for registration, diagnosis and follow-up].
    Guttormsen AB; Harboe T; Florvaag E
    Tidsskr Nor Laegeforen; 2000 Jan; 120(1):127. PubMed ID: 10815508
    [No Abstract]   [Full Text] [Related]  

  • 40. Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report.
    Dammak A; Taillé C; Marinho E; Crestani B; Crickx B; Descamps V
    Br J Dermatol; 2012 Jun; 166(6):1375-6. PubMed ID: 22233356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.